Cargando…
Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388330/ https://www.ncbi.nlm.nih.gov/pubmed/34465964 http://dx.doi.org/10.4103/iju.IJU_547_20 |
| _version_ | 1783742617383600128 |
|---|---|
| author | Talwar, Harkirat Singh |
| author_facet | Talwar, Harkirat Singh |
| author_sort | Talwar, Harkirat Singh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8388330 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83883302021-08-30 Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer Talwar, Harkirat Singh Indian J Urol Uroscan Wolters Kluwer - Medknow 2021 2021-07-01 /pmc/articles/PMC8388330/ /pubmed/34465964 http://dx.doi.org/10.4103/iju.IJU_547_20 Text en Copyright: © 2021 Indian Journal of Urology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Uroscan Talwar, Harkirat Singh Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer |
| title | Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer |
| title_full | Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer |
| title_fullStr | Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer |
| title_full_unstemmed | Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer |
| title_short | Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer |
| title_sort | docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer |
| topic | Uroscan |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388330/ https://www.ncbi.nlm.nih.gov/pubmed/34465964 http://dx.doi.org/10.4103/iju.IJU_547_20 |
| work_keys_str_mv | AT talwarharkiratsingh docetaxelabirateroneenzalutamideapalutamideinpatientswithmetastatichormonesensitiveprostatecancer |